AAAAAA
Results:
1-14
|
Results: 14
Authors:
BERNSEN MR
VANDERVELDEN AW
EVERSE LA
DULLENS HFJ
DENOTTER W
HEINTZ APM
Citation: Mr. Bernsen et al., INTERLEUKIN-2 - HOPE IN CASES OF CISPLATIN-RESISTANT TUMORS, Cancer immunology and immunotherapy, 46(1), 1998, pp. 41-47
Authors:
EVERSE LA
BERNSEN MR
DULLENS HFJ
DENOTTER W
Citation: La. Everse et al., PRIMING OF THE ANTITUMOR RESPONSE PROMOTES EFFICACY OF INTERLEUKIN-2 THERAPY, Cancer immunology and immunotherapy, 44(4), 1997, pp. 221-229
Authors:
EVERSE LA
RENES IB
JURGENLIEMKSCHULZ IM
RUTGERS DH
BERNSEN MR
DULLENS HFJ
DENOTTER W
BATTERMANN JJ
Citation: La. Everse et al., LOCAL LOW-DOSE INTERLEUKIN-2 INDUCES SYSTEMIC IMMUNITY WHEN COMBINED WITH RADIOTHERAPY OF CANCER - A PRECLINICAL STUDY, International journal of cancer, 72(6), 1997, pp. 1003-1007
Authors:
VOSHOL H
DULLENS HFJ
DENOTTER W
VLIEGENTHART JFG
Citation: H. Voshol et al., THE GLYCOSYLATION PROFILE OF INTERLEUKIN-2 ACTIVATED HUMAN-LYMPHOCYTES CORRELATES TO THEIR ANTITUMOR-ACTIVITY, Anticancer research, 16(1), 1996, pp. 155-159
Authors:
MACCARRONE M
NIEUWENHUIZEN WF
DULLENS HFJ
CATANI MV
MELINO G
VELDINK GA
VLIEGENTHART JFG
AGRO AF
Citation: M. Maccarrone et al., MEMBRANE MODIFICATIONS IN HUMAN ERYTHROLEUKEMIA K562 CELLS DURING INDUCTION OF PROGRAMMED CELL-DEATH BY TRANSFORMING GROWTH-FACTOR-BETA-1 OR CISPLATIN, European journal of biochemistry, 241(1), 1996, pp. 297-302
Authors:
BERNSEN MR
DULLENS HFJ
DENOTTER W
HEINTZ APM
Citation: Mr. Bernsen et al., REEVALUATION OF THE SUPERIORITY OF POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN-2 OVER REGULAR RECOMBINANT INTERLEUKIN-2, Journal of interferon & cytokine research, 15(7), 1995, pp. 641-645
Authors:
BERGERS JJ
DENOTTER W
DULLENS HFJ
DEGROOT JW
STEERENBERG PA
FILIUS PMG
CROMMELIN DJA
Citation: Jj. Bergers et al., EFFECT OF IMMUNOMODULATORS ON SPECIFIC TUMOR-IMMUNITY INDUCED BY LIPOSOME-ENCAPSULATED TUMOR-ASSOCIATED ANTIGENS, International journal of cancer, 56(5), 1994, pp. 721-726
Authors:
MAAS RA
DULLENS HFJ
HENK D
VANWEERING J
DEMIK HJI
KOTEN JW
BELGER RJ
DENOTTER W
Citation: Ra. Maas et al., HISTOLOGICAL ANALYSIS OF IL-2 INDUCED REGRESSION OF MURINE SOLID SL2-TUMORS, Biotherapy, 6(2), 1993, pp. 83-91
Authors:
BERGERS JJ
DENOTTER W
DULLENS HFJ
KERKVLIET CTM
CROMMELIN DJA
Citation: Jj. Bergers et al., INTERLEUKIN-2-CONTAINING LIPOSOMES - INTERACTION OF INTERLEUKIN-2 WITH LIPOSOMAL BILAYERS AND PRELIMINARY STUDIES ON APPLICATION IN CANCER VACCINES, Pharmaceutical research, 10(12), 1993, pp. 1715-1721
Authors:
BERGERS JJ
DENOTTER W
DULLENS HFJ
DEGROOT JW
STEERENBERG PA
MIMPEN MWH
CROMMELIN DJA
Citation: Jj. Bergers et al., CRITICAL FACTORS FOR LIPOSOME-INCORPORATED TUMOR-ASSOCIATED ANTIGENS TO INDUCE PROTECTIVE TUMOR-IMMUNITY TO SL2 LYMPHOMA-CELLS IN MICE, Cancer immunology and immunotherapy, 37(4), 1993, pp. 271-279
Authors:
DULLENS HFJ
RADEMAKERS LHPM
DOFFEMONT M
VANVEEN PT
BULDER R
DENOTTER W
Citation: Hfj. Dullens et al., INVOLVEMENT OF THE OMENTAL LYMPHOID ORGAN IN THE INDUCTION OF PERITONEAL IMMUNITY AGAINST TUMOR-CELLS, Invasion & metastasis, 13(5), 1993, pp. 267-276
Authors:
MAAS RA
BECKER MJ
WEIMAR IS
DENOOY JC
DULLENS HFJ
DENOTTER W
Citation: Ra. Maas et al., TRANSFER OF TUMOR-IMMUNITY BY BOTH CD4-INFILTRATING T-LYMPHOCYTES ACTIVATED IN-VIVO BY IL-2 THERAPY OF TUMOR-BEARING MICE( AND CD8+ TUMOR), Immunobiology, 188(3), 1993, pp. 281-292
Authors:
VOSHOL H
DULLENS HFJ
DENOTTER W
VLIEGENTHART JFG
Citation: H. Voshol et al., HUMAN NATURAL-KILLER-CELLS - A CONVENIENT PURIFICATION PROCEDURE AND THE INFLUENCE OF CRYOPRESERVATION ON CYTOTOXIC ACTIVITY, Journal of immunological methods, 165(1), 1993, pp. 21-30
Authors:
BERNSEN MR
VANBARLINGEN HJJ
VANDERVELDEN AW
DULLENS HFJ
DENOTTER W
HEINTZ APM
Citation: Mr. Bernsen et al., DUALISTIC EFFECTS OF CIS-DIAMMINE-DICHLORO-PLATINUM ON THE ANTITUMOR EFFICACY OF SUBSEQUENTLY APPLIED RECOMBINANT INTERLEUKIN-2 THERAPY - ATUMOR-DEPENDENT PHENOMENON, International journal of cancer, 54(3), 1993, pp. 513-517
Risultati:
1-14
|